Biofarm (BSE:BIO) Additional Paid-In Capital : lei-0.2 Mil(As of Mar. 2025)

View and export this data going back to 1996. Start your Free Trial

What is Biofarm Additional Paid-In Capital?

Biofarm's quarterly additional paid-in capital stayed the same from Sep. 2024 (lei-0.2 Mil) to Dec. 2024 (lei-0.2 Mil) and stayed the same from Dec. 2024 (lei-0.2 Mil) to Mar. 2025 (lei-0.2 Mil).

Biofarm's annual additional paid-in capital stayed the same from Dec. 2022 (lei-0.2 Mil) to Dec. 2023 (lei-0.2 Mil) and stayed the same from Dec. 2023 (lei-0.2 Mil) to Dec. 2024 (lei-0.2 Mil).

Biofarm Additional Paid-In Capital Historical Data

The historical data trend for Biofarm's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biofarm Additional Paid-In Capital Chart

Biofarm Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Additional Paid-In Capital

Get a 7-Day Free Trial

-0.17

Biofarm Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Additional Paid-In Capital	Get a 7-Day Free Trial															-0.17	-0.17	-0.17	-0.17	-0.17

Biofarm Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Biofarm Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Biofarm's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Biofarm Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofarm SA (BSE:BIO) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

99 Logofatul Tautu Street, Sector 3, Bucharest, ROU, 031212

Website

https://www.biofarm.ro

Biofarm SA is a company engaged in production and marketing in the pharmaceutical sector. It is involved in the manufacture and wholesale of over-the-counter drugs, prescription medications, and dietary supplements. The firm's product portfolio includes pharmaceutical preparations for the digestive system, musculoskeletal system, immune stimulation, respiratory system, cold & flu symptoms, and venous circulation improvement, as well as multivitamins, antioxidants, antiseptics, disinfectants, and cosmetics, among others. Some of its brands are Triferment, Colebil, Cavit, Anghirol, Clorocalcin, and Bixtonim. Additionally, the company offers services, such as investment in research, promotion, and packaging.